Science Explorer Back to mapMap

Most cited papers from Baruch S. Blumberg Institute

What are the most cited papers from Baruch S. Blumberg Institute?

The most cited paper from Baruch S. Blumberg Institute is "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (Daniel J. Klionsky et al., 2021), with 2,743 citations. Next come "Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5" (1,597) and "A Review of the Microbial Production of Bioactive Natural Products and Biologics" (571).

Showing 50 of 60 papers. Every paper with more than 88 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
2 Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5 Hiroki Kato, Osamu Takeuchi, Eriko Mikamo-Satoh et al. · The Journal of Experimental Medicine Open access 30 Jun 2008 1,597
3 A Review of the Microbial Production of Bioactive Natural Products and Biologics Janette V. Pham, Mariamawit A. Yilma, Adriana Feliz et al. · Frontiers in Microbiology Open access 20 Jun 2019 571
4 GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma Jorge A. Marrero, Patrick R. Romano, Ольга Викторовна Николаева et al. · Journal of Hepatology 29 Jun 2005 367
5 Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA Formation Haitao Guo, Dong Jiang, Tianlun Zhou et al. · Journal of Virology Open access 5 Sep 2007 340
6 The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 Lisa M Force et al. · The Lancet Open access1,377 authors 25 Sep 2025 330
7 Present and future therapies of hepatitis B: From discovery to cure T. Jake Liang, Timothy M. Block, Brian J. McMahon et al. · Hepatology Open access 3 Aug 2015 321
8 Hepatocellular Carcinoma: Etiology and Current and Future Drugs Aastha Jindal, Anusha Thadi, Kunwar Shailubhai · Journal of Clinical and Experimental Hepatology Open access 27 Jan 2019 270
9 Inhibition of Hepatitis B Virus Replication by the Host Zinc Finger Antiviral Protein Richeng Mao, Hui Nie, Dawei Cai et al. · PLoS Pathogens Open access 11 Jul 2013 247
10 Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology Xuanmao Jiao, Omar Nawab, Tejal Amar Patel et al. · Cancer Research Open access 10 Jul 2019 240
11 New insights into protein–protein interaction modulators in drug discovery and therapeutic advance Hossam Nada, Yongseok Choi, Sung-Do Kim et al. · Signal Transduction and Targeted Therapy Open access 5 Dec 2024 218
12 Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation Dawei Cai, Courtney Mills, Wenquan Yu et al. · Antimicrobial Agents and Chemotherapy Open access 29 May 2012 218
13 Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells Jinhong Chang, Ju‐Tao Guo, Dong Jiang et al. · Journal of Virology Open access 13 Jun 2008 210
14 DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus Yonghe Qi, Zhenchao Gao, Guangwei Xu et al. · PLoS Pathogens Open access 26 Oct 2016 208
15 Applications of Bioisosteres in the Design of Biologically Active Compounds Nicholas A. Meanwell · Journal of Agricultural and Food Chemistry 24 Mar 2023 207
16 Interferon induction of IFITM proteins promotes infection by human coronavirus OC43 Xuesen Zhao, Fang Guo, Fei Liu et al. · Proceedings of the National Academy of Sciences Open access 21 Apr 2014 206
17 A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook Anna Kramvis et al. · Nature Reviews Gastroenterology & Hepatology ReviewOpen access 20 Jul 2022 188
18 Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression Junyi Hu et al. · Nature Genetics Open access 15 Feb 2024 187
19 Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2 Xuesen Zhao, Danying Chen, Robert Szabla et al. · Journal of Virology Open access 13 Jul 2020 182
20 Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids Matthew Campagna, Fei Liu, Richeng Mao et al. · Journal of Virology Open access 10 Apr 2013 181
21 Redox Regulation of Caspase-3(-like) Protease Activity: Regulatory Roles of Thioredoxin and Cytochrome c Shugo Ueda, Hajime Nakamura, Hiroshi Masutani et al. · The Journal of Immunology Dec 1998 175
22 LOX-1 Supports Adhesion of Gram-Positive and Gram-Negative Bacteria Takeshi Shimaoka, Noriaki Kume, Manabu Minami et al. · The Journal of Immunology Apr 2001 173
23 Netrin-G1: a Novel Glycosyl Phosphatidylinositol-Linked Mammalian Netrin That Is Functionally Divergent from Classical Netrins Toshiaki Nakashiba, Toshio Ikeda, Sachiko Nishimura et al. · Journal of Neuroscience Open access Sep 2000 167
24 IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections Xuesen Zhao, Jiarui Li, Cheryl Ann Winkler et al. · Frontiers in Microbiology Open access 8 Jan 2019 160
25 Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics Ju‐Tao Guo, Haitao Guo · Antiviral Research Open access 10 Aug 2015 153
26 Distinct Developmental Modes and Lesion-Induced Reactions of Dendrites of Two Classes ofDrosophilaSensory Neurons Kaoru Sugimura, Misato Yamamoto, Ryusuke Niwa et al. · Journal of Neuroscience Open access May 2003 151
27 Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Dana Bryazka et al. · The Lancet Public Health Open access1,009 authors Oct 2024 148
28 Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction Pathway Haitao Guo, Tianlun Zhou, Dong Jiang et al. · Journal of Virology Open access 4 Jul 2007 148
29 An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign‐Born Persons Living in the United States Robert J. Wong, Carol L. Brosgart, Sue Welch et al. · Hepatology Open access 3 Mar 2021 146
30 Biomarkers for the Early Detection of Hepatocellular Carcinoma Neehar D. Parikh, Anand S. Mehta, Amit G. Singal et al. · Cancer Epidemiology Biomarkers & Prevention Open access Apr 2020 145
31 Preferential Selection of Human T-Cell Leukemia Virus Type 1 Provirus Lacking the 5′ Long Terminal Repeat during Oncogenesis Maki Miyazaki, Jun‐ichirou Yasunaga, Yuko Taniguchi et al. · Journal of Virology Open access 8 Mar 2007 142
32 Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses Xuesen Zhao, Mohit Sehgal, Zhifei Hou et al. · Journal of Virology Open access 18 Dec 2017 138
33 Inhibition of Borna disease virus replication by an endogenous bornavirus-like element in the ground squirrel genome Kan Fujino, Masayuki Horie, Tomoyuki Honda et al. · Proceedings of the National Academy of Sciences Open access 25 Aug 2014 137
34 CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion Xuanmao Jiao et al. · Cancer Research Open access 22 Jan 2018 132
35 Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA Yuanjie Liu, Hui Nie, Richeng Mao et al. · PLoS Pathogens Open access 11 Apr 2017 129
36 Chronic hepatitis B: What should be the goal for new therapies? Timothy M. Block, Robert G. Gish, Haitao Guo et al. · Antiviral Research Open access 5 Feb 2013 129
37 Production and Function of the Cytoplasmic Deproteinized Relaxed Circular DNA of Hepadnaviruses Haitao Guo, Richeng Mao, Timothy M. Block et al. · Journal of Virology Open access 29 Oct 2009 129
38 microbeMASST: a taxonomically informed mass spectrometry search tool for microbial metabolomics data Simone Zuffa et al. · Nature Microbiology Open access109 authors 5 Feb 2024 125
39 Indoleamine 2,3-Dioxygenase Mediates the Antiviral Effect of Gamma Interferon against Hepatitis B Virus in Human Hepatocyte-Derived Cells Richeng Mao, Jiming Zhang, Dong Jiang et al. · Journal of Virology Open access 17 Nov 2010 125
40 Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis Anand S. Mehta, Ronald E. Long, Mary Ann Comunale et al. · Journal of Virology Open access 29 Nov 2007 125
41 Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus Chunxiao Xu, Haitao Guo, Xiao‐Ben Pan et al. · Journal of Virology Open access 8 Jul 2010 124
42 HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways Fang Guo, Qiong Zhao, Muhammad Abdullah Sheraz et al. · PLoS Pathogens Open access 25 Sep 2017 122
43 STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus Fang Guo, Yanxing Han, Xuesen Zhao et al. · Antimicrobial Agents and Chemotherapy Open access 16 Dec 2014 122
44 Design, Synthesis, and Biological Evaluation of Triazolo-pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion Wenquan Yu, Cally Goddard, Elizabeth Clearfield et al. · Journal of Medicinal Chemistry Open access 25 Jul 2011 122
45 An overview of rapamycin: from discovery to future perspectives Young Ji Yoo, Hanseong Kim, Sung Ryeol Park et al. · Journal of Industrial Microbiology & Biotechnology 9 Sep 2016 117
46 Activation of Pattern Recognition Receptor-Mediated Innate Immunity Inhibits the Replication of Hepatitis B Virus in Human Hepatocyte-Derived Cells Haitao Guo, Dong Jiang, Dongling Ma et al. · Journal of Virology Open access 29 Oct 2008 116
47 A research agenda for curing chronic hepatitis B virus infection Harvey J. Alter et al. · Hepatology Open access 6 Sep 2017 113
48 Biological functions of CDK5 and potential CDK5 targeted clinical treatments Alison B. Shupp, Mathew Craig Casimiro, Richard G. Pestell · Oncotarget Open access 6 Jan 2017 113
49 LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2 Xuesen Zhao, Shuangli Zheng, Danying Chen et al. · Journal of Virology Open access 8 Jul 2020 104
50 Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates Murugaiah A. M. Subbaiah, Jarkko Rautio, Nicholas A. Meanwell · Chemical Society Reviews Review 2024 102

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.